More articles from Supplement

Pharmacology and Pharmacokinetics of the Newer Generation Aromatase Inhibitors
Aman U. Buzdar

Clinical Cancer Research Jan 2003, 9 (1) 468s-472s;
Clinical Differences among the Aromatase Inhibitors
Jennifer A. Ligibel, Eric P. Winer

Clinical Cancer Research Jan 2003, 9 (1) 473s-479s;
Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer
James N. Ingle

Clinical Cancer Research Jan 2003, 9 (1) 480s-485s;
Adjuvant Hormonal Therapy for Premenopausal Women with Breast Cancer
Leisha A. Emens, Nancy E. Davidson

Clinical Cancer Research Jan 2003, 9 (1) 486s-494s;
National Surgical Adjuvant Breast and Bowel Project Update
Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Walter M. Cronin

Clinical Cancer Research Jan 2003, 9 (1) 495s-501s;
Preoperative Models to Evaluate Endocrine Strategies for Breast Cancer
Mitch Dowsett

Clinical Cancer Research Jan 2003, 9 (1) 502s-510s;
ErbB (HER) Receptors Can Abrogate Antiestrogen Action in Human Breast Cancer by Multiple Signaling Mechanisms
Hirokazu Kurokawa, Carlos L. Arteaga

Clinical Cancer Research Jan 2003, 9 (1) 511s-515s;
New Mechanisms of Signal Transduction Inhibitor Action
Adrian V. Lee, Rachel Schiff, Xiaojiang Cui, Deepali Sachdev, Douglas Yee, Andrew P. Gilmore, Charles H. Streuli, Steffi Oesterreich, Darryl L. Hadsell

Clinical Cancer Research Jan 2003, 9 (1) 516s-523s;
Integration of Signal Transduction Inhibitors with Endocrine Therapy
Stephen R. D. Johnston, Julia Head, Sunil Pancholi, Simone Detre, Lesley-Ann Martin, Ian E. Smith, Mitch Dowsett

Clinical Cancer Research Jan 2003, 9 (1) 524s-532s;
Predictions from a Preclinical Model
Angela Brodie, Danijela Jelovac, Brian J. Long

Clinical Cancer Research Jan 2003, 9 (1) 455s-459s;

Main menu

User menu

Search

More articles from Supplement

Pages

Articles

Info for

About Clinical Cancer Research